Internal Medicine, Rheumatology · Sewell, NJ
NPI
1821309154
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
150 Delsea Dr, Suite B
Sewell, NJ, 08080
Phone (856) 302-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
79,770 services
Medicare patients, 2024
193
Average age 73
Drug cost, 2024
$3.8M
1,283 prescriptions
Company payments, 2025
$35K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nickolas M Tyris was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 33,600 times for 14 patients. In total Nickolas M Tyris billed 79,770 services in 34 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 33,600 | 14 | $3.59 | $121K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,700 | 26 | $0.10 | $276 |
| J0897 Injection, denosumab, 1 mg | Office | 2,460 | 30 | $20.83 | $51K |
| 99214 Office E&M - Established | Office | 501 | 167 | $103.90 | $52K |
| 96401 Chemotherapy Administration | Office | 298 | 55 | $61.67 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 257 | 136 | $13.46 | $3,459 |
| 96413 Chemotherapy Administration | Office | 165 | 38 | $111.46 | $18K |
| 20611 Joint Injection | Office | 92 | 27 | $91.82 | $8,448 |
| 99204 Office E&M - New | Office | 88 | 87 | $136.46 | $12K |
By year: 2022 $1.1M for 108,106 services; 2023 $1.5M for 98,074 services; 2024 $1.0M for 79,770 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nickolas M Tyris prescribed most often to Medicare patients was Prednisone, with 130 prescriptions and refills. In total Nickolas M Tyris wrote 1,283 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 130 | 180 | 47 | $1,225 |
| Methotrexate Methotrexate Sodium | 97 | 257 | 39 | $2,955 |
| Hydroxychloroquine Sulfate Generic | 95 | 276 | 42 | $5,657 |
| Gabapentin Generic | 76 | 192 | 26 | $1,438 |
| Meloxicam Generic | 76 | 192 | 31 | $367 |
| Tramadol Hcl Generic | 76 | 85 | 29 | $414 |
| Allopurinol Generic | 53 | 155 | 19 | $770 |
| Amitriptyline Hcl Generic | 41 | 123 | 14 | $1,349 |
| Alendronate Sodium Generic | 33 | 89 | Under 11 | $429 |
| Leflunomide Generic | 32 | 92 | 11 | $1,749 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 32 | 32 | Under 11 | $231 |
| Pregabalin Generic | 26 | 72 | 12 | $1,006 |
| Orencia Abatacept/Maltose | 22 | 22 | Under 11 | $112K |
| Duloxetine Hcl Generic | 22 | 52 | Under 11 | $448 |
| Methylprednisolone Generic | 21 | 21 | 15 | $274 |
Brand drugs: - claims; generic drugs: 1,071 claims; opioid claims: 137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nickolas M Tyris $35K ($35K in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 40 | $13K |
| ANI Pharmaceuticals, Inc. ANIP | 31 | $11K |
| GlaxoSmithKline, LLC. GSK | 16 | $4,906 |
| Janssen Biotech, Inc. JNJ | 24 | $2,340 |
| Abbvie Inc. ABBV | 34 | $693 |
| Mallinckrodt Hospital Products Inc. | 15 | $437 |
| UCB, Inc. UCB.BR | 22 | $418 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $279 |
| Novartis Pharmaceuticals Corporation NVS | 27 | $265 |
| Genzyme Corporation SNY | 8 | $201 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.